SCP
CVS icon

Stamos Capital Partners’s CVS Health CVS Stock Holding History

Stamos Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.62M Sell
54,289
-24,433
-31% -$2.18M 0.86% 43
2026
Q1 		$5.65M Buy
78,722
+10,874
+16% +$838K 0.88% 30
2025
Q4 		$5.38M Buy
67,848
+29,233
+76% +$2.3M 0.87% 32
2025
Q3 		$2.91M Sell
38,615
-18,899
-33% -$1.3M 0.55% 49
2025
Q2 		$3.97M Buy
57,514
+6,659
+13% +$437K 0.71% 45
2025
Q1 		$3.45M Sell
50,855
-45,405
-47% -$2.72M 0.9% 27
2024
Q4 		$4.32M Buy
96,260
+9,000
+10% +$505K 1.01% 25
2024
Q3 		$5.49M Sell
87,260
-32,880
-27% -$1.92M 1.29% 21
2024
Q2 		$7.1M Buy
120,140
+68,270
+132% +$4.27M 1.51% 13
2024
Q1 		$4.14M Buy
51,870
+9,250
+22% +$707K 0.94% 25
2023
Q4 		$3.37M Buy
+42,620
New +$3.03M 0.91% 23
2023
Q1 		– Sell
-10,700
Closed -$997K – 110
2022
Q4 		$997K Buy
10,700
+5,550
+108% +$536K 0.32% 74
2022
Q3 		$491K Buy
+5,150
New +$510K 0.12% 145
2020
Q4 		– Sell
-26,000
Closed -$1.52M – 59
2020
Q3 		$1.52M Buy
26,000
+8,000
+44% +$498K 0.56% 33
2020
Q2 		$1.17M Sell
18,000
-8,657
-32% -$545K 0.67% 33
2020
Q1 		$1.58M Buy
+26,657
New +$1.78M 0.83% 39
2019
Q3 		– Sell
-4,500
Closed -$247K – 45
2019
Q2 		$247K Buy
+4,500
New +$242K 0.25% 48
2019
Q1 		– Sell
-24,000
Closed -$1.57M – 79
2018
Q4 		$1.57M Buy
+24,000
New +$1.79M 1.19% 30

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Stamos Capital Partners's CVS Position: Q2 2026 in Review

Stamos Capital Partners reduced its CVS Health (CVS) stake by 31% in Q2 2026, selling an estimated $2.18M and leaving 54,289 shares worth $5.62M. The position accounts for 0.86% of the portfolio, ranked #43.

Stamos Capital Partners first reported a position in CVS in Q4 2018 and has held it in 18 quarters since. The position peaked at $7.1M in Q2 2024. 2,069 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Stamos Capital Partners held 54,289 shares of CVS Health worth $5.62M as of Q2 2026.
  • Stamos Capital Partners sold 24,433 CVS Health shares in Q2 2026, an estimated $2.18M.
  • CVS Health made up 0.86% of Stamos Capital Partners's portfolio in Q2 2026, its #43 holding.
  • Stamos Capital Partners first reported a position in CVS Health in Q4 2018 and has held it in 18 quarters since.
  • Stamos Capital Partners's CVS Health position peaked at $7.1M in Q2 2024.
  • 2,069 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Stamos Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.